ReferIndia News Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

ReferIndia News

Sponsored

आज का राशिफल पढ़ें — जानें आपका दिन कैसा रहेगा

Check Now
News Image

Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

Published on: May 1, 2026, 3:16 p.m. | Source: NDTV Profit

Available in 100 mg and 400 mg formulations, the originator product Avastin is marketed by Roche/Genentech, filing added.

Checkout more news
Ad Banner

One Partner for All Your Financial Goals

From financial planning and insurance to portfolio management and retirement solutions—get everything under one trusted roof.

Book Consultation
ReferIndia News contact